Clinical Trial

A Study on the Novel Oncolytic Virus Combined With PD-1 Inhibitor in the Treatment of Recurrent High-grade Glioma

Name: A Study on the Novel Oncolytic Virus Combined With PD-1 Inhibitor in the Treatment of Recurrent High-grade Glioma — clinical trial record (NCT07472790)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

A single-arm clinical study on the efficacy and safety of the novel oncolytic virus Ad-TD-nsIL12 combined with PD-1 inhibitors in the treatment of recurrent high-grade glioma

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-03-12.

Trial Details

NCT Number	NCT07472790
Lead Sponsor	Beijing Bio-Targeting Therapeutics Technology Co., Ltd
Conditions	High-grade Glioma
Enrollment	15 participants
Start Date	2026-07-31
Primary Completion	2028-04-30 (estimated)
Study Completion	2028-04-30 (estimated)
Updated on ClinicalTrials.gov	2026-07-14